Literature DB >> 7441018

Gentamicin inactivation in purulent exudates: role of cell lysis.

P Vaudaux, F A Waldvogel.   

Abstract

Factors contributing to the binding and reversible inactivation of gentamicin by purulent exudates were studied in a simplified in vitro model consisting of purified human polymorphonuclear leukocytes (PMNLs). Whereas intact PMNLs (10(6)-10(8)/ml) bound almost no [14C]gentamicin, freeze-thawed PMNLs showed extensive [14C]gentamicin binding, expressed as antibiotic cosedimenting with particulate material from the lysed PMNLs. Antibiotic binding could be related to the concentration of lysed PMNLs and to the amount of [14C]gentamicin added. Binding of [14C]gentamicin by lysed PMNLs was highly sensitive to DNase I but was unaffected by RNase, Triton X-100, or protease. Purified chromatin or DNA from either purulent exudates or lysed PMNLs reproduced the [14C]gentamicin-binding pattern obtained with crude PMNL lysate. These results show that gentamicin inactivation in purulent exudates can be correlated with binding of the antibiotic to lysed PMNLs; PMNL chromatin DNA is identified as one of the major binding factors.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7441018     DOI: 10.1093/infdis/142.4.586

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  14 in total

Review 1.  Antibiotic tissue penetration and its relevance: models of tissue penetration and their meaning.

Authors:  D E Nix; S D Goodwin; C A Peloquin; D L Rotella; J J Schentag
Journal:  Antimicrob Agents Chemother       Date:  1991-10       Impact factor: 5.191

2.  Pasteurella haemolytica leukotoxin-induced increase in phospholipase A2 activity in bovine neutrophils.

Authors:  Z Wang; C Clarke; K Clinkenbeard
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

Review 3.  Alternative strategies for proof-of-principle studies of antibacterial agents.

Authors:  Axel Dalhoff; Andrej Weintraub; Carl Erik Nord
Journal:  Antimicrob Agents Chemother       Date:  2014-05-27       Impact factor: 5.191

4.  Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum.

Authors:  S Shak; D J Capon; R Hellmiss; S A Marsters; C L Baker
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

5.  Behavior of antibiotics during human necrotizing pancreatitis.

Authors:  C Bassi; P Pederzoli; S Vesentini; M Falconi; A Bonora; H Abbas; A Benini; E M Bertazzoni
Journal:  Antimicrob Agents Chemother       Date:  1994-04       Impact factor: 5.191

6.  Influence of inflammation on the efficacy of antibiotic treatment of experimental pyelonephritis.

Authors:  P R Meylan; G Braoudakis; M P Glauser
Journal:  Antimicrob Agents Chemother       Date:  1986-05       Impact factor: 5.191

7.  Correlation of tobramycin-induced inhibition of protein synthesis with postantibiotic effect in Escherichia coli.

Authors:  S Barmada; S Kohlhepp; J Leggett; R Dworkin; D Gilbert
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191

8.  Effect of tobramycin on protein synthesis in 2-deoxystreptamine aminoglycoside-resistant clinical isolates of Haemophilus influenzae.

Authors:  J Levy; J L Burns; P M Mendelman; K Wong; K Mack; A L Smith
Journal:  Antimicrob Agents Chemother       Date:  1986-03       Impact factor: 5.191

9.  New sodium hydroxide digestion method for measurement of renal tobramycin concentrations.

Authors:  D N Gilbert; S J Kohlhepp
Journal:  Antimicrob Agents Chemother       Date:  1986-09       Impact factor: 5.191

10.  Macromolecular mechanisms of sputum inhibition of tobramycin activity.

Authors:  B E Hunt; A Weber; A Berger; B Ramsey; A L Smith
Journal:  Antimicrob Agents Chemother       Date:  1995-01       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.